Download our representation to the 2021 Spending Review.
CaSE has been undertaking a significant body of work ahead of this years crucial Spending Review. Alongside this formal representation, we produced a five point roadmap to enable the UK to become a ‘science superpower’.
Last week CaSE published analysis shows the effect of the Government delaying reaching its R&D target by three years – a potential loss of £11bn of private investment. CaSE has also published further analysis showing that the UK has stagnated on R&D over last 20 years as comparator nations have rushed forward, and that the UK target for the next five years is least ambitious of comparator nations – other nations pushing for much further and faster R&D growth.
CaSE also joined 32 other leading organisations to call on the Chancellor to use the upcoming Spending Review to commit to delivering £22bn of public investment in R&D by 2024/25.
Download the full representation
DownloadRelated resources
‘High-level mapping’ and past comparisons
03 March 2026
Analysis of ‘high-level mapping’ of the new UKRI ‘buckets’ system and what they tell us about UK R&D funding.
CaSE letter to UKRI CEO Prof Sir Ian Chapman
24 February 2026
Following discourse surrounding UKRI’s new funding model and the specific impact of some changes to the STFC, CaSE have written to ask for further clarity on some key areas.
Our latest information on UKRI changes
13 February 2026
In the last few days CaSE have had multiple opportunities to hear from and have discussions directly with UKRI’s CEO Prof Sir Ian Chapman.
What is happening with UKRI funding and the STFC cuts?
03 February 2026
In recent days there have been a number of reports about cuts to UKRI budgets and grant funding pauses. Here we summarise events so far, and set out why we believe UKRI should explain how and why decisions have been made.